Insmed Shares Are Trading Higher After Wells Fargo Maintained an Overweight Rating on the Stock and Maintained Its Price Target of $55
在富國銀行維持對該股的增持評級並維持其55美元的目標股價之後,Insmed股價走高
Insmed Shares Are Trading Higher After Wells Fargo Maintained an Overweight Rating on the Stock and Maintained Its Price Target of $55
在富國銀行維持對該股的增持評級並維持其55美元的目標股價之後,Insmed股價走高
使用瀏覽器的分享功能,分享給你的好友吧